These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10699610)

  • 1. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
    Pannek J; Sommerfeld HJ; Bötel U; Senge T
    Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder.
    Kaplinsky R; Greenfield S; Wan J; Fera M
    J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
    Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E
    BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
    Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
    Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.
    Di Stasi SM; Giannantoni A; Vespasiani G; Navarra P; Capelli G; Massoud R; Stephen RL
    J Urol; 2001 Feb; 165(2):491-8. PubMed ID: 11176403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical oxybutynin for spinal cord injury patients.
    Szollar SM; Lee SM
    Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients.
    Haferkamp A; Staehler G; Gerner HJ; Dörsam J
    Spinal Cord; 2000 Apr; 38(4):250-4. PubMed ID: 10822396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin.
    Di Stasi SM; Giannantoni A; Navarra P; Capelli G; Storti L; Porena M; Stephen RL
    J Urol; 2001 Dec; 166(6):2232-6. PubMed ID: 11696741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
    Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
    Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction.
    Buyse G; Verpoorten C; Vereecken R; Casaer P
    J Urol; 1998 Sep; 160(3 Pt 2):1084-7; discussion 1092. PubMed ID: 9719281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    Amark P; Bussman G; Eksborg S
    Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
    O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
    J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
    Painter KA; Vates TS; Bukowski TP; Fleming P; Freedman AL; Smith CA; Gonzalez R; Perlmutter AD
    J Urol; 1996 Oct; 156(4):1459-62. PubMed ID: 8808907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Oral Fesoterodine Be an Alternative for Intravesical Oxybutynin Instillations in Children with Neuropathic Bladder Dysfunction?
    van den Heijkant M; De Coster K; Jansen K; Bogaert G
    Urol Int; 2019; 103(2):202-210. PubMed ID: 31117096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany].
    Schindler O; Ho H; Leidl Q; Angermund A; Elishar R; Frech-Dörfler M; Hirsch A; Kalke YB; Kirschner-Herrmanns R; Tornic J; Queissert F; Rahnama'i S; Rehme C; Reitz A; Schmitz F; Schultz-Lampel D; Gedamke M
    Urologie; 2024 Jul; 63(7):693-701. PubMed ID: 38755461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia.
    Goessl C; Knispel HH; Fiedler U; Härle B; Steffen-Wilke K; Miller K
    Urology; 1998 Jan; 51(1):94-8. PubMed ID: 9457296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
    George J; Tharion G; Richar J; Macaden AS; Thomas R; Bhattacharji S
    ScientificWorldJournal; 2007 Oct; 7():1683-90. PubMed ID: 17982563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.